RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ORMP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Oramed Pharmaceuticals Inc. stock downgraded from Hold/Accumulate to Sell Candidate after Wednesday trading session.
(Updated on Mar 27, 2024)

Sell candidate since Mar 27, 2024 PDF

The Oramed Pharmaceuticals Inc. stock price gained 3.68% on the last trading day (Wednesday, 27th Mar 2024), rising from $2.72 to $2.82. During the last trading day the stock fluctuated 6.39% from a day low at $2.66 to a day high of $2.83. The price has been going up and down for this period, and there has been a 1.81% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 71 thousand more shares were traded than the day before. In total, 160 thousand shares were bought and sold for approximately $451.24 thousand.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.73 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 27.46% during the next 3 months and, with a 90% probability hold a price between $3.48 and $4.93 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ORMP Signals & Forecast

Oramed Pharmaceuticals Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Oramed Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.83 and $3.04. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -21.23%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Oramed Pharmaceuticals Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.39 and $2.32. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Oramed Pharmaceuticals Inc. finds support just below today's level at $2.39. If this is broken, then the next support from accumulated volume will be at $2.32 and $2.18.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.170 between high and low, or 6.39%. For the last week, the stock has had daily average volatility of 6.37%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ORMP) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Oramed Pharmaceuticals Inc. to open at $2.77, and during the day (based on 14 day Average True Range), to move between $2.64 and $3.00, which gives a possible trading interval of +/-$0.183 (+/-6.49%) up or down from last closing price. If Oramed Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 12.97% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.98 (5.67%) than the support at $2.39 (15.25%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Oramed Pharmaceuticals Inc. stock A Buy?

The Oramed Pharmaceuticals Inc. stock holds several negative signals and despite the positive trend, we believe Oramed Pharmaceuticals Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -2.119 Sell Candidate Downgraded

Predicted Opening Price for Oramed Pharmaceuticals Inc. of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$2.77 ( 1.77%) $2.82

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ORMP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.94 4.26 %
R2 2.88 1.95 %
R1 2.83 0.530 %
Current price: 2.82
Support S1 2.71 -4.08 %
S2 2.66 -5.50 %
S3 2.60 -7.80 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.14 11.35 %
R2 3.00 6.21 %
R1 2.98 5.67 %
Current price 2.82
Support S1 2.39 -15.25%
S2 2.32 -17.73%
S3 2.18 -22.70%

FAQ

What is the symbol for Oramed Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Oramed Pharmaceuticals Inc. is ORMP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Oramed Pharmaceuticals Inc. Stock?
The Oramed Pharmaceuticals Inc. stock holds several negative signals and despite the positive trend, we believe Oramed Pharmaceuticals Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Oramed Pharmaceuticals Inc. Stock?
Oramed Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Oramed Pharmaceuticals Inc. Stock.

What's the current price of Oramed Pharmaceuticals Inc. Stock?
As of the end of day on the 2024-03-27, the price of an Oramed Pharmaceuticals Inc. (ORMP) share was $2.82.

What is the 52-week high and low for Oramed Pharmaceuticals Inc. Stock?
The 52-week high for Oramed Pharmaceuticals Inc. Stock is $5.25 and the 52-week low is $1.68.

What is the market capitalization of Oramed Pharmaceuticals Inc. Stock?
As of the 2024-03-27, the market capitalization of Oramed Pharmaceuticals Inc. is 110.212M.

When is the next earnings date for Oramed Pharmaceuticals Inc.?
The upcoming earnings date for Oramed Pharmaceuticals Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals. Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptid... ORMP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT